13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-11-06 Event 2026-11-06 SEC 0001140361-26-042524 →

Frisco Holding II → HCA Healthcare, Inc. HCA

Stake: 33.80% Shares: 38,882,521 CUSIP: 40412C101 Class: Common Stock, par value $0.01 per share
Composite Decision Signal · AVOID (DILUTION / EXIT TRAP) Conviction Score: 25/100
Disqualifiers: INSIDER_LIQUIDATION_INTO_CATALYST: $16.32M insider selling into catalyst (±14d)
  • Active Schedule 13D filer baseline
  • High conviction ownership stake (33.8%)
  • Held by 1 tracked 13F institutional manager
  • 26 NPORT-P mutual funds holding CUSIP
  • Moderate short days-to-cover (4.6 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
1 13D/G filings on this issuer
0 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-10-15
DTC 4.60
4,906,014 shares short · +0.4% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $16.67M
Point72 Asset Mgmt

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →